Search
for
Sort by
Research 271–300 of 1000+
- Microneedle-Based Approaches for Skin Disease Treatment
- Anatomy and Physiology of the Skin
- Cutaneous complications of chemotherapeutic agents
- Biocompatible nanoparticles and vesicular systems in transdermal drug delivery for various skin diseases
- Drug-Induced Skin, Nail and Hair Disorders
- EFFECT OF "AMINOPTERIN" ON EPITHELIAL TISSUES
- Cutaneous reactions to recombinant cytokine therapy
- What causes hidradenitis suppurativa ?—15 years after
- Niosomes as a propitious carrier for topical drug delivery
- Adverse Cutaneous Reactions to Antipsychotics
- Cutaneous manifestations of HIV infection other than Kaposi's sarcoma: Clinical and histologic aspects
- Dermatologic Manifestations of Human Immunodeficiency Virus Infection
- Adverse Cutaneous Reactions to Mood Stabilizers
- Adverse Cutaneous Reactions to Antidepressants
- Regulatory T cells in inflammatory skin disease: from mice to humans
- Clinico-epidemiological and Mycological Aspects of Tinea Incognito in Iran: A 16-Year Study
- CLINICAL AND LABORATORY EVALUATION OF AIDS TRICHOPATHY
- Cutaneous Lesions in Systemic Lupus Erythematosus
- Interventions for morphea
- Consensus on the use of oral isotretinoin in dermatology - Brazilian Society of Dermatology
- Dermatological Manifestations of Stress in Normal and Psychiatric Populations
- Adverse cutaneous reactions to chemotherapeutic agents and cytokine therapy
- Lupus erythematosus: considerations about clinical, cutaneous and therapeutic aspects
- Drug eruptions in dermatology
- Cardiodermatology: the heart of the connection between the skin and cardiovascular disease
- An overview of zinc and its importance in dermatology-Part II: The association of zinc with some dermatologic disorders
- Anticytokine therapy, particularly anti-IFN-γ, in Th1-mediated autoimmune diseases
- Approach to Patients with Suspected Rheumatic Disease
- Nonmalignant late cutaneous changes after allogeneic hematopoietic stem cell transplant in children
- The Cutaneous Side Effects of Selective BRAF Inhibitors and Anti-CTLA4 Agents: the Growing Role of the Dermatologist in the Management of Patients with Metastatic Melanoma